ObsEva SA NASDAQ:OBSV is reporting this earnings, what to expect.

0
558

ObsEva SA NASDAQ:OBSV is reporting this earnings, what to expect.

ObsEva SA NASDAQ:OBSV headquartered in Switzerland is reporting their earnings on 05/16/2018 before the bell. Street forecast for the quarter ending March 2018 is $-0.46.

According to stock market daily analyst this is Lower then same time previous year. ObsEva SA, reported EPS for the same quarter last year was $-0.58.

()
()

Chart

Overview of ObsEva SA NASDAQ:OBSV

Founded in Switzerland in November 2012, ObsEva is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious conditions that compromise a woman’s reproductive health and pregnancy.

ObsEva is led by a strong management team with substantial experience in successfully developing and commercializing pharmaceutical products in our target market. ObsEva’s team members include trained obstetricians and gynecologists with an in-depth understanding of patient and physician needs. Our expertise has led to the development of new and innovative therapies that have the potential to improve patient outcomes in reproductive health.

OBSV
Change
% Change
Market Cap
% Change from 52 Week Low
% Change from 52 Week High
Shares Outstanding
Volume
Dividend Rate

Fusion Connect NASDAQ:FSNN is reporting this earnings, what to expect.